Clinical Trial

Oral Immunotherapy for Egg Allergy in Children Aged 6 to 16

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 10, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
The aim of the study is to determine the efficacy of a 12-month egg oral immunotherapy (OIT) protocol with a cooked whole egg product including yolk and egg white. Study hypothesis: With this method the risk for severe allergic reaction to egg protein is reduced and the diet can partly or completely be normalized.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-02-13; most recent amendment 2024-04-09.
Trial Details
NCT Number NCT05740163
Lead Sponsor Tampere University Hospital
Collaborators: University of Oulu, Oulu University Hospital
Conditions Egg Allergy
Enrollment 60 participants
Start Date 2019-12-30
Primary Completion 2024-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-04-10